Open AccessReal-world experience of the clinical effectiveness of omalizumab use in Qatar – a study protocol
Author(s) -
Saleema Purayil,
Hassan Mobayed,
Maryam AlNesf
Publication year - 2022
Publication title -
qatar medical journal
Language(s) - English
Resource type - Journals
eISSN - 2227-0426
pISSN - 0253-8253
DOI - 10.5339/qmj.2022.fqac.3
Subject(s) - omalizumab , medicine , asthma , atopic dermatitis , allergy , adverse effect , immunoglobulin e , clinical trial , biosimilar , intensive care medicine , dermatology , immunology , antibody